Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Kore Fiber

Preclinical

KKolosis Bio, LLC

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

LumbarNot yet recruiting

LumbarPreclinical

Not yet recruiting

Timeline

Expected Milestones

Q4 2028

PreclinicalNot yet recruiting

Lumbar

NCT07868510

Clinical

Trials by Indication[1]

Lumbar1 trial

A Prospective, Randomized Controlled Trial of Kore Fiber® Versus Autograft in Posterolateral Lumbar Fusion (PLF)

Not yet recruiting·KKolosis Bio, LLC·Preclinical·NCT07868510·75 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Kore Fiber. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Kore Fiber. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Kolosis Bio, LLC company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: KKolosis Bio, LLC

Related News